Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 02 2023
23 02 2023
Historique:
received:
16
11
2022
accepted:
06
02
2023
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
Remdesivir (GS-5734; VEKLURY) is a single diastereomer monophosphoramidate prodrug of an adenosine analog (GS-441524). Remdesivir is taken up by target cells and metabolized in multiple steps to form the active nucleoside triphosphate (GS-443902), which acts as a potent inhibitor of viral RNA-dependent RNA polymerases. Remdesivir and GS-441524 have antiviral activity against multiple RNA viruses. Here, we expand the evaluation of remdesivir's antiviral activity to members of the families Flaviviridae, Picornaviridae, Filoviridae, Orthomyxoviridae, and Hepadnaviridae. Using cell-based assays, we show that remdesivir can inhibit infection of flaviviruses (such as dengue 1-4, West Nile, yellow fever, Zika viruses), picornaviruses (such as enterovirus and rhinovirus), and filoviruses (such as various Ebola, Marburg, and Sudan virus isolates, including novel geographic isolates), but is ineffective or is significantly less effective against orthomyxoviruses (influenza A and B viruses), or hepadnaviruses B, D, and E. In addition, remdesivir shows no antagonistic effect when combined with favipiravir, another broadly acting antiviral nucleoside analog, and has minimal interaction with a panel of concomitant medications. Our data further support remdesivir as a broad-spectrum antiviral agent that has the potential to address multiple unmet medical needs, including those related to antiviral pandemic preparedness.
Identifiants
pubmed: 36823196
doi: 10.1038/s41598-023-29517-9
pii: 10.1038/s41598-023-29517-9
pmc: PMC9950143
doi:
Substances chimiques
remdesivir
3QKI37EEHE
Antiviral Agents
0
Adenosine Monophosphate
415SHH325A
Alanine
OF5P57N2ZX
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3131Informations de copyright
© 2023. The Author(s).
Références
PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389
pubmed: 28231247
J Gen Virol. 2001 Jun;82(Pt 6):1283-1290
pubmed: 11369871
Clin Pharmacol Ther. 2020 Aug;108(2):242-247
pubmed: 32246834
PLoS One. 2017 Jan 17;12(1):e0169648
pubmed: 28095508
Sci Rep. 2017 Mar 06;7:43395
pubmed: 28262699
J Med Chem. 2017 Mar 9;60(5):1648-1661
pubmed: 28124907
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
J Infect Dis. 2020 Nov 9;222(11):1894-1901
pubmed: 32479636
Nat Commun. 2019 May 22;10(1):2265
pubmed: 31118422
Nat Commun. 2020 Oct 15;11(1):5214
pubmed: 33060595
Sci Transl Med. 2019 May 29;11(494):
pubmed: 31142680
Front Microbiol. 2020 Jun 12;11:1105
pubmed: 32595613
PLoS Negl Trop Dis. 2014 May 01;8(5):e2804
pubmed: 24786461
Sci Rep. 2021 Sep 30;11(1):19458
pubmed: 34593911
Front Pharmacol. 2021 Aug 13;12:706901
pubmed: 34483914
J Biol Chem. 2022 Feb;298(2):101529
pubmed: 34953856
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Sci Rep. 2019 Jul 10;9(1):10021
pubmed: 31292511
Antiviral Res. 2019 Sep;169:104541
pubmed: 31233808
Curr Opin Virol. 2016 Jun;18:126-34
pubmed: 27344481
Viruses. 2021 Oct 06;13(10):
pubmed: 34696439
PLoS Negl Trop Dis. 2022 Mar 8;16(3):e0010220
pubmed: 35259154
J Med Chem. 2021 Apr 22;64(8):5001-5017
pubmed: 33835812
Antiviral Res. 2019 Nov;171:104592
pubmed: 31473342
PLoS Negl Trop Dis. 2016 May 10;10(5):e0004695
pubmed: 27163257
Future Med Chem. 2021 Jan;13(1):5-8
pubmed: 33225723
Clin Pharmacokinet. 2016 Aug;55(8):907-23
pubmed: 26798032
Expert Rev Anti Infect Ther. 2015 Apr;13(4):417-25
pubmed: 25695406
Sci Transl Med. 2020 Apr 29;12(541):
pubmed: 32253226
Pharmacol Rev. 1989 Jun;41(2):93-141
pubmed: 2692037
Gastroenterology. 2014 Apr;146(4):1070-83
pubmed: 24361467
Nature. 2016 Mar 17;531(7594):381-5
pubmed: 26934220
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
Antimicrob Agents Chemother. 2010 Aug;54(8):3099-106
pubmed: 20516274
Cell Host Microbe. 2016 Jun 8;19(6):891-900
pubmed: 27198478
Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7
pubmed: 22446091
Antiviral Res. 2013 May;98(2):242-7
pubmed: 23470860
Emerg Microbes Infect. 2020 Dec;9(1):2256-2265
pubmed: 32981479
Proc Soc Exp Biol Med. 1966 Jan;121(1):190-3
pubmed: 4285768
Cell Rep. 2021 Jul 27;36(4):109450
pubmed: 34289384
Nucleic Acids Res. 2022 May 17;:
pubmed: 35580060
Virology. 1990 Jun;176(2):643-7
pubmed: 2345967
Nat Commun. 2021 Nov 5;12(1):6415
pubmed: 34741049
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
Sci Transl Med. 2022 May 4;14(643):eabm3410
pubmed: 35315683
Antimicrob Agents Chemother. 2010 Dec;54(12):5269-80
pubmed: 20837762
Molecules. 2022 Jun 14;27(12):
pubmed: 35744940
Emerg Infect Dis. 1995 Jan-Mar;1(1):1-6
pubmed: 8903147
Antiviral Res. 2009 Jun;82(3):95-102
pubmed: 19428599
Drugs. 2020 Sep;80(13):1355-1363
pubmed: 32870481